BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025.
World J Clin Cases. Nov 16, 2025; 13(32): 111134
Published online Nov 16, 2025. doi: 10.12998/wjcc.v13.i32.111134
Table 1 Ratio female:male in different pathologies
Condition
Female:male ratio
Ref.
Typical MS-related ON2-3:1Malik et al[5] and Arnett et al[4]
Multiple sclerosis (overall)2.73:1 (95 %CI: 2.37-3.09)Arnett et al[4]
AQP4-NMOSD (overall)8.89:1Arnett et al[4]
HIV-positive NMOSD9-10:1Borisow et al[6]
HIV-negative NMOSD≈ 2:1Borisow et al[6]
MOGAD≈ 1:1 (some series female > male)Jurynczyk et al[10] and de Mol et al[14]
Table 2 Main hormones and their immunomodulating action
Hormone (life-phase)
Key immunomodulatory actions
Principal experimental/clinical observations
Estradiol/estriol (mid-cycle, pregnancy)↓ TNF-α, IFN-γ; ↑ IL-10; ER-β activation quiets microglia and CD11c+ cells; promotes oligodendrocyte maturation and remyelinationThird-trimester pregnancy sharply lowers MS/ON relapse rates; women retain more RNFL after ON in high-estrogen states
Progesterone (luteal phase, gestation)Shifts immunity Th1 → Th2; expands T-regs; suppresses iNOS and Toll-like-receptor signaling; fosters myelin repairColor-Doppler shows ↑ central-retinal-artery resistance; progesterone analogues ameliorate EAE lesions and enhance remyelination
Testosterone/DHT (male dominance, peri-puberty)Down-regulates Th1/Th17; induces thymic AIRE; inhibits NF-κB & p38-MAPK in microglia; curtails IL-1β, IL-6, TNF-α; modulates Bax/Bcl-2, caspase-3Androgen supplementation dampens EAE severity; low testosterone correlates with aggressive MS & greater ON severity in men; DHT shields SH-SY5Y neurons from inflammatory apoptosis
Prolactin (lactation, immune-cell secretion)Dual role – may boost inflammation yet stimulates oligodendrocyte progenitorsHuman data inconclusive; experimental models show both aggravation of EAE and promotion of remyelination